Gallic acid ameliorates hyperglycemia and improves hepatic carbohydrate metabolism in rats fed a high-fructose diet

• Published in: Nutrition research (New York, N.Y.) N.Y.), 2016-02, Vol.36 (2), p.150-160
• Main Authors: Huang, Da-Wei, Chang, Wen-Chang, Wu, James Swi-Bea, Shih, Rui-Wen, Shen, Szu-Chuan
• Format: Article
• Language: English
• Subjects: Animals; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Anti-Inflammatory Agents, Non-Steroidal - metabolism; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Antioxidants - administration & dosage; Antioxidants - metabolism; Antioxidants - therapeutic use; C-Peptide - antagonists & inhibitors; C-Peptide - blood; Carbohydrate Metabolism; Cell Line; Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - diet therapy; Diabetes Mellitus, Type 2 - immunology; Diabetes Mellitus, Type 2 - metabolism; Dietary Carbohydrates - adverse effects; Dietary Supplements; Fructosamine - antagonists & inhibitors; Fructosamine - blood; Fructose - adverse effects; Gallic acid; Gallic Acid - administration & dosage; Gallic Acid - metabolism; Gallic Acid - therapeutic use; Gastroenterology and Hepatology; Gene Expression Regulation; Hepatitis - complications; Hepatitis - prevention & control; Hepatocytes - immunology; Hepatocytes - metabolism; Hepatocytes - pathology; High-fructose diet; Hyperglycemia; Hyperglycemia - prevention & control; Hypoglycemic Agents - administration & dosage; Hypoglycemic Agents - metabolism; Hypoglycemic Agents - therapeutic use; Insulin Resistance; Male; Mice; Oxidative Stress; Rat; Rats, Wistar
• ISSN: 0271-5317; 1879-0739
• DOI: 10.1016/j.nutres.2015.10.001

Abstract Herein, we investigated the hypoglycemic effect of plant gallic acid (GA) on glucose uptake in an insulin-resistant cell culture model and on hepatic carbohydrate metabolism in rats with a high-fructose diet (HFD)–induced diabetes. Our hypothesis is that GA ameliorates hyperglycemia via alleviating hepatic insulin resistance by suppressing hepatic inflammation and improves abnormal hepatic carbohydrate metabolism by suppressing hepatic gluconeogenesis and enhancing the hepatic glycogenesis and glycolysis pathways in HFD-induced diabetic rats. Gallic acid increased glucose uptake activity by 19.2% at a concentration of 6.25 μ g/mL in insulin-resistant FL83B mouse hepatocytes. In HFD-induced diabetic rats, GA significantly alleviated hyperglycemia, reduced the values of the area under the curve for glucose in an oral glucose tolerance test, and reduced the scores of the homeostasis model assessment of insulin resistance index. The levels of serum C-peptide and fructosamine and cardiovascular risk index scores were also significantly decreased in HFD rats treated with GA. Moreover, GA up-regulated the expression of hepatic insulin signal transduction–related proteins, including insulin receptor, insulin receptor substrate 1, phosphatidylinositol-3 kinase, Akt/protein kinase B, and glucose transporter 2, in HFD rats. Gallic acid also down-regulated the expression of hepatic gluconeogenesis–related proteins, such as fructose-1,6-bisphosphatase, and up-regulated expression of hepatic glycogen synthase and glycolysis-related proteins, including hexokinase, phosphofructokinase, and aldolase, in HFD rats. Our findings indicate that GA has potential as a health food ingredient to prevent diabetes mellitus.